Agencia SINC echoes the interest of pharmaceutical multinationals in Iproteos. Founded in 2011 by Teresa Tarragó, this biotechnology company is a spin-off of IRB Barcelona. Since then, Tarragó aimed to convert a molecule (IPR-19) discovered during her research into a drug. This molecule has great potential for the treatment of cognitive problems caused by schizophrenia.
Link to Agencia SINC
Biocat news channel interviews Oscar Flores, co-founder and CEO of Made of Genes. An IRB Barcelona alumnus, Oscar did his PhD in Biomedicine at IRB Barcelona and the Barcelona Supercomputing Center (BSC).
Made of Genes focuses on transactional genomics, helping individuals and companies obtain, store, move, manage and analyse genetic and biomedical data safely and in compliance with legal regulations. Their goal: “For everyone to have their gene sequence in their back pocket and be able to use it every time they go to the doctor,” sums up Oscar Flores.
In the interview, Oscar Flores ...
A study done by IRB Barcelona inspires a school in Castellón to carry out a project on food that has been selected as a finalist in an international initiative called "I CAN School Challenge". This news is reported by the newspaper Levante, El Mercantil Valenciano.
"We know what we eat ", a project done by third year primary school pupils at the state school Assumpció de la Vall d'Uixó in Castellón, has been chosen as a finalist from among the 121 participants in the competition "I CAN School Challenge". This competition forms part of the "Design for Change España" movement, an international initiative that seeks to give kids aged from 8 to 15 the opportunity to change the...
Farmanatur has echoed that Sin Alcohol S.L. and the Spanish Association against Cancer (abbreviated to AECC in Spanish) have agreed to launch two exclusive dealcoholized wines. For each bottle of WIN.O White or Red sold, 0.60 € will be devoted to a study financed by the AECC. Dr. Jelena Urosevic, with IRB Barcelona's Growth Control and Cancer Metastasis group, will coordinate the project, which will address the role of phosphatases in colorectal cancer.
Link to Farmanatur
Several media, including Periodistas en Español, have highlighted the research performed by the group headed by ICREA Professor Marco Milan. The study reveals the ability of tumours of epithelial origin to grow in the absence of a tumour microenvironment. The researchers examined the growth of a tumour in the absence of adjacent cell populations like the immune system or mesenchymal cells.
Link to Periodistas en...
The Diari de Girona gives voice to the study of the group of the ICREA researcher Salvador Aznar Benitah on the rhythmic functions of stem cells. This study refutes the commonly held belief that aging is associated with the loss of the circadian rhythm of stem cells. In this regard, it reveals that these cells continue to work rhythmically during aging, although their functions are reprogrammed during this period.
Link to ...
The radio programme of RNE Laboratorio de Jal has referred to the study of Miquel Coll’s group on the resistance of Staphylococcus aureus to antibiotics. This lethal bacterium has a mechanism by which antibiotic resistance genes are transferred.
Thanks to the resolution of a three-dimensional structure of the complex formed by relaxase with a fragment of the plasmid DNA, the researchers have identified an amino acid as a pivotal element of the transfer.
Link to ...
The newspaper Heraldo de Soria.Extensa interviews Salvador Aznar Benitah, ICREA researcher at IRB Barcelona and winner of the Premio Nacional de la Fundación Científica Caja Rural de Soria.
The interview focuses on the study published in Nature in December 2016, in which the IRB Barcelona researchers discovered that the protein CD36 enhances cancer metastasis. This protein makes the tumour cell take up fatty acids. The scientists demonstrated that the inhibition of this protein causes a dramatic decrease in the metastatic capacity of certain kinds of tumour....
Roger Gomis, ICREA researcher at IRB Barcelona and founder of Inbiomotion, is one of the five entrepreneurs interviewed in a report published in Ara Emprenem, the supplement of the newspaper ARA. Five companies explain how they have turned their fight against cancer into a business model. Inbiomotion is working on a biomarker to predict bone metastases.
Link to the feature article in ARAEmprenem
The science news portal Madri+d echoes on the release of the video “Meet Our Scientists” about the research into colon cancer conducted by Eduard Batlle, ICREA researcher at IRB Barcelona.
The Madri+d news bulletin reaches more than 60,000 subscribers.